BETHESDA, MD—With this year's flu season little more than an achy, sneezy memory, the Vaccine and Related Biological Products Advisory Committee has begun to select antigenic strains for the first influenza vaccine of the 21st century.
The committee has recommended retaining the current component of influenza A(H1N1), the strain known as A/Beijing/262/95, and has deferred a recommendation for A(H3N2) and the B strain.
Marwick C. Millennial Influenza Vaccine. JAMA. 1999;281(10):887-888. doi:10.1001/jama.281.10.887-JMN0310-5-1